Psychedelics News Thread 🧵
1/ On December 29, 2025, Enveric Biosciences announced the issuance of U.S. Patent No. 12,492,179 covering a class of chemically modified mescaline derivatives designed for the treatment of neuropsychiatric conditions. The patent does not claim natural mescaline from cacti or peyote itself.